Physician profile
Allen Degges
NPI 1053817486
$3,719.71
in general payments reported to CMS, 2019-2025
7 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $424 · 2023: $1,655 · 2024: $1,497 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,776 · Travel and Lodging: $1,500 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.56 |
| Travel and Lodging | $1,499.96 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,882.70 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $312.45 | 2023 | Proclaim, Eterna |
| Avanos Medical | $270.29 | 2023 | Generator |
| Medtronic, INC. | $97.31 | 2023 | Intellis Adaptivestim |
| Nevro Corp. | $83.33 | 2023 | Senza |
| Bioventus LLC | $53.63 | 2024-2025 | Durolane |
| Merz Pharmaceuticals, LLC | $20.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Degges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.